精神病の世界市場レポート 2025年

精神病市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.8％で、131億3,000万米ドルに成長します。予測期間の成長は、ストレスおよび関連リスク因子の有病率の増加、ライフスタイルの変化によるメンタルヘルス負担の増加、政府のイニシアチブの拡大、マインドフルネスに基づく介入や治療プログラムの採用拡大、メンタルヘルス研究や革新的治療への投資の増加に起因すると考えられます。主な動向としては、新規薬物療法の開発、診断技術の進歩、革新的な注射薬の導入、バイオマーカーの利用、個別化医薬品の需要拡大などが挙げられます。

メンタルヘルス疾患の罹患率の上昇は、精神病市場の成長を牽引すると予想されます。メンタルヘルス疾患には、個人の気分、思考、行動、全体的な精神的幸福に影響を及ぼす障害が含まれます。これらの疾患の増加は、ストレスレベルの上昇、ライフスタイルの変化、社会的孤立、経済的圧力、遺伝的素因などの要因に起因しています。精神病治療は早期診断、医療介入、専門的治療を通じて患者をサポートし、抗精神病薬の使用や治療法の選択肢を増やすことにつながります。例えば、米国を拠点とする団体である全米精神疾患同盟（National Alliance on Mental Illness）は2024年、米国の18～44歳の個人において、精神病スペクトラムおよび気分障害が年間約60万件の入院を占めていると報告しています。その結果、精神疾患の有病率の上昇が精神病市場の成長を促進しています。

精神病市場の各社は、インタラクティブでパーソナライズされたメンタルヘルス介入を通じて治療成果を高めるため、バーチャルリアリティ（VR）心理療法の進展に注力しています。VR心理療法は、制御されたコンピュータ生成環境に個人を没入させることで、苦痛を軽減し、認知機能を改善し、誘導介入を通じて社会的スキルを高め、症状管理への安全かつ効果的なアプローチを提供します。例えば、2022年4月、米国のデジタル・セラピューティクス企業であるOxfordVR社は、没入型の仮想シナリオの中で認知行動療法（CBT）を通じて患者を誘導するように設計されたプラットフォームであるgameChangeVRを発表しました。この自動化されたVRセラピーは、週6回のセッションで提供され、特に重度の心理的課題に直面している人に対して、被害妄想の軽減や全体的なQOLの向上など、大きな効果が実証されました。この革新的な技術は、効果的なメンタルヘルスケアへのアクセスを拡大し、臨床医不足に対処し、重度の精神疾患を抱える数百万人の患者に拡張可能なソリューションを提供する可能性を秘めています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界精神病 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の精神病市場：成長率分析
• 世界の精神病市場の実績：規模と成長, 2019-2024
• 世界の精神病市場の予測：規模と成長, 2024-2029, 2034F
• 世界精神病総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の精神病市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤
• カプセル
• 注射
• 世界の精神病市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 統合失調症
• 双極性障害
• 単極性うつ病
• 痴呆
• その他の病気の種類
• 世界の精神病市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン
• オフライン
• 世界の精神病市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ヘルスケアクリニック
• 専門クリニック
• その他のエンドユーザー
• 世界の精神病市場タブレットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗精神病薬錠剤
• 気分安定剤
• 世界の精神病市場カプセルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗精神病薬カプセル
• 抗うつ薬カプセル
• 世界の精神病市場、注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 長時間作用型注射抗精神病薬
• 短時間作用型注射抗精神病薬

第7章 地域別・国別分析

• 世界の精神病市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の精神病市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 精神病市場：競合情勢
• 精神病市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis International AG
• GlaxoSmithKline plc
• Takeda Pharmaceuticals Inc.
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co.
• Biogen Idec
• Dr. Reddy's Laboratories Ltd.
• Lundbeck A/S
• Gedeon Richter
• Alkermes
• Supernus Pharmaceuticals
• Acadia Pharmaceuticals
• Neuron Pharmaceuticals
• Mapi Pharma

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 精神病市場2029：新たな機会を提供する国
• 精神病市場2029：新たな機会を提供するセグメント
• 精神病市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Psychosis is a mental health condition in which individuals lose touch with reality, experiencing hallucinations, delusions, and disorganized thinking. Rather than being a disorder itself, it is a symptom of various mental illnesses. Early detection enhances treatment outcomes, and effective care through medication, therapy, and support can help individuals regain stability.

The primary types of products for psychosis include tablets, capsules, and injections. Tablets are widely used due to their convenience and precise dosing, ensuring consistent drug levels for effective treatment. The condition encompasses various disease types, including schizophrenia, bipolar disorder, unipolar depression, dementia, and others. These products are distributed through both online and offline channels and are utilized by various end-users, such as hospitals, healthcare clinics, specialty clinics, and others.

The psychosis market research report is one of a series of new reports from The Business Research Company that provides psychosis market statistics, including the psychosis industry global market size, regional shares, competitors with the psychosis market share, detailed psychosis market segments, market trends, and opportunities, and any further data you may need to thrive in the psychosis industry. This psychosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psychosis market size has grown strongly in recent years. It will grow from $9.88 billion in 2024 to $10.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising cases of mental health conditions, an increasing demand for mental health therapeutics, the widespread adoption of typical antipsychotics, the expanding use of cognitive behavioral therapy, and the prevalence of stress-inducing global and economic conditions.

The psychosis market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the increasing prevalence of stress and associated risk factors, the rising mental health burden due to lifestyle changes, expanding government initiatives, the growing adoption of mindfulness-based interventions and therapy programs, and increasing investments in mental health research and innovative treatments. Major trends include the development of novel drug therapies, advancements in diagnostic technologies, the introduction of innovative injectable drugs, the use of biomarkers, and the growing demand for personalized medicines.

The rising incidence of mental health conditions is expected to drive the growth of the psychosis market. Mental health conditions encompass disorders that affect an individual's mood, thinking, behavior, and overall mental well-being. The increase in these conditions is attributed to factors such as heightened stress levels, lifestyle changes, social isolation, economic pressures, and genetic predisposition. Psychosis treatments support patients through early diagnosis, medical intervention, and specialized therapies, leading to greater use of antipsychotic medications and therapeutic options. For example, in 2024, the National Alliance on Mental Illness, a US-based organization, reported that among individuals in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations annually. As a result, the rising prevalence of mental health conditions is fueling the growth of the psychosis market.

Companies in the psychosis market are focusing on advancing virtual reality (VR) psychological therapy to enhance treatment outcomes through interactive and personalized mental health interventions. VR psychological therapy involves immersing individuals in controlled, computer-generated environments to reduce distress, improve cognitive function, and enhance social skills through guided interventions, offering a safe and effective approach to symptom management. For instance, in April 2022, OxfordVR, a US-based digital therapeutics company, introduced gameChangeVR, a platform designed to guide patients through cognitive behavioral therapy (CBT) in immersive virtual scenarios. The automated VR therapy, delivered over six weekly sessions, demonstrated significant benefits, particularly for individuals facing severe psychological challenges, by reducing paranoia and enhancing overall quality of life. This innovative technology has the potential to expand access to effective mental health care, addressing clinician shortages and providing a scalable solution for millions of patients with severe mental illness.

In March 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired Karuna Therapeutics for $14 billion. This acquisition aims to strengthen Bristol Myers Squibb's neuroscience portfolio by incorporating KarXT, a novel antipsychotic, and expanding its pipeline with potential treatments for schizophrenia, Alzheimer's disease, and other mental health disorders. Karuna Therapeutics is a US-based biopharmaceutical company specializing in the development of psychosis medications.

Major players in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics.

North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in psychosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the psychosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The psychosis market consists of sales of transdermal patches, nasal sprays, intravenous (IV) infusions, long-acting injectable (LAI) implants, and inhalable formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psychosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psychosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psychosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The psychosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Tablet; Capsule; Injection
• 2) By Disease Type: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Disease Types
• 3) By Distribution Channel: Online; Offline
• 4) By End-User: Hospitals; Healthcare Clinics; Speciality Clinics; Other End-Users
• Subsegments:
• 1) By Tablet: Antipsychotic Tablets; Mood Stabilizer Tablets
• 2) By Capsule: Antipsychotic Capsules; Antidepressant Capsules
• 3) By Injection: Long-acting Injectable Antipsychotics; Short-acting Injectable Antipsychotics
• Companies Mentioned:Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Psychosis Market Characteristics

3. Psychosis Market Trends And Strategies

4. Psychosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Psychosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Psychosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Psychosis Market Growth Rate Analysis
• 5.4. Global Psychosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Psychosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Psychosis Total Addressable Market (TAM)

6. Psychosis Market Segmentation

• 6.1. Global Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Capsule
• Injection
• 6.2. Global Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Schizophrenia
• Bipolar Disorder
• Unipolar Depression
• Dementia
• Other Disease Types
• 6.3. Global Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Psychosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Healthcare Clinics
• Speciality Clinics
• Other End-Users
• 6.5. Global Psychosis Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antipsychotic Tablets
• Mood Stabilizer Tablets
• 6.6. Global Psychosis Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antipsychotic Capsules
• Antidepressant Capsules
• 6.7. Global Psychosis Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-acting Injectable Antipsychotics
• Short-acting Injectable Antipsychotics

7. Psychosis Market Regional And Country Analysis

• 7.1. Global Psychosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Psychosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Psychosis Market

• 8.1. Asia-Pacific Psychosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Psychosis Market

• 9.1. China Psychosis Market Overview
• 9.2. China Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Psychosis Market

• 10.1. India Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Psychosis Market

• 11.1. Japan Psychosis Market Overview
• 11.2. Japan Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Psychosis Market

• 12.1. Australia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Psychosis Market

• 13.1. Indonesia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Psychosis Market

• 14.1. South Korea Psychosis Market Overview
• 14.2. South Korea Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Psychosis Market

• 15.1. Western Europe Psychosis Market Overview
• 15.2. Western Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Psychosis Market

• 16.1. UK Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Psychosis Market

• 17.1. Germany Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Psychosis Market

• 18.1. France Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Psychosis Market

• 19.1. Italy Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Psychosis Market

• 20.1. Spain Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Psychosis Market

• 21.1. Eastern Europe Psychosis Market Overview
• 21.2. Eastern Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Psychosis Market

• 22.1. Russia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Psychosis Market

• 23.1. North America Psychosis Market Overview
• 23.2. North America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Psychosis Market

• 24.1. USA Psychosis Market Overview
• 24.2. USA Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Psychosis Market

• 25.1. Canada Psychosis Market Overview
• 25.2. Canada Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Psychosis Market

• 26.1. South America Psychosis Market Overview
• 26.2. South America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Psychosis Market

• 27.1. Brazil Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Psychosis Market

• 28.1. Middle East Psychosis Market Overview
• 28.2. Middle East Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Psychosis Market

• 29.1. Africa Psychosis Market Overview
• 29.2. Africa Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Psychosis Market Competitive Landscape And Company Profiles

• 30.1. Psychosis Market Competitive Landscape
• 30.2. Psychosis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Psychosis Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. GlaxoSmithKline plc
• 31.3. Takeda Pharmaceuticals Inc.
• 31.4. Eli Lilly and Company
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Otsuka Pharmaceutical Co.
• 31.7. Biogen Idec
• 31.8. Dr. Reddy's Laboratories Ltd.
• 31.9. Lundbeck A/S
• 31.10. Gedeon Richter
• 31.11. Alkermes
• 31.12. Supernus Pharmaceuticals
• 31.13. Acadia Pharmaceuticals
• 31.14. Neuron Pharmaceuticals
• 31.15. Mapi Pharma

32. Global Psychosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Psychosis Market

34. Recent Developments In The Psychosis Market

35. Psychosis Market High Potential Countries, Segments and Strategies

• 35.1 Psychosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Psychosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Psychosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer